Published: Monday 1 December 2014
Last year, the researchers behind the CLOTS 3 trial showed that intermittent pneumatic compression (IPC) sleeves reduced the risk of deep vein thrombosis (DVT) and improved survival in immobile patients with stroke. The results were published in the journal, The Lancet.
In a research article released in this month's edition of the journal, The Lancet Neurology, the researchers conducted a second analysis of the data they collected. They looked at how the use of IPC sleeves impacted the disability, living circumstances, quality of life and hospital costs in the stroke patients who took part in CLOTS 3.
The results showed that there were no significant differences in disability, living circumstances and health-related quality of life among immobile patients with stroke who had used IPC sleeves and those that did not.
The results also showed that IPC sleeves were an inexpensive treatment (compared to the costs associated with DVT and death), and that they prevent DVT and improve survival.
As such, the research suggests that clinicians should take into account all these potential effects when deciding to treat stroke patients with IPC sleeves.